Abstract | AIMS: MAIN METHODS: MTT assay was used to determine the cell viability. Cell cycle analysis was performed to identify apoptosis. Apoptosis was confirmed by detecting cytoplasmic histone-associated- DNA-fragments using a cell death detection ELISAPLUS kit. The expression of proteins was evaluated by Western blot. Reverse transcriptase-polymerase chain reaction was employed to detect the expression of mRNA. KEY FINDINGS: Cytotoxic effect of luteolin was higher in cancer cell line SK-Hep-1 cells than in normal cell line AML12 cells. Luteolin led a significantly increase in apoptosis accompanied by activation of caspase 8, -9 and -3 and cleavage of poly (ADP-ribose) polymerase (PARP), which was completely blocked by Z-VAD-FMK, a pan caspase inhibitor. Luteolin significantly downregulated the expression of X-linked inhibitor of apoptosis (XIAP), Mcl-1 and Bid. Furthermore, luteolin effectively decreased OPN expression at both mRNA and protein level. Exogenous OPN markedly blocked apoptosis induction, caspases activation, PARP cleavage, downregulation of XIAP and Mcl-1 in luteolin-treated cells. Luteolin impaired the AKT pathway by inhibiting the phosphorylation of AKT. SC79, an AKT activator, blocked apoptosis induction, caspases activation, PARP cleavage, downregulation of OPN, XIAP, Mcl-1 and Bid in luteolin-treated cells. SIGNIFICANCE: These results demonstrated that luteolin inhibits the AKT/OPN pathway, thereby inducing caspase-dependent apoptosis in human HCC SK-Hep-1 cells with little toxicity.
|
Authors | Eunji Im, Changhwan Yeo, Eun-Ok Lee |
Journal | Life sciences
(Life Sci)
Vol. 209
Pg. 259-266
(Sep 15 2018)
ISSN: 1879-0631 [Electronic] Netherlands |
PMID | 30107166
(Publication Type: Journal Article)
|
Copyright | Copyright © 2018 Elsevier Inc. All rights reserved. |
Chemical References |
- Biomarkers, Tumor
- Caspase Inhibitors
- SPP1 protein, human
- Osteopontin
- Poly(ADP-ribose) Polymerases
- Proto-Oncogene Proteins c-akt
- Caspases
- Luteolin
|
Topics |
- Apoptosis
(drug effects)
- Biomarkers, Tumor
(genetics, metabolism)
- Carcinoma, Hepatocellular
(drug therapy, genetics, metabolism, pathology)
- Caspase Inhibitors
(pharmacology)
- Caspases
(chemistry, metabolism)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Liver Neoplasms
(drug therapy, genetics, metabolism, pathology)
- Luteolin
(pharmacology)
- Osteopontin
(genetics, metabolism)
- Poly(ADP-ribose) Polymerases
(genetics, metabolism)
- Proto-Oncogene Proteins c-akt
(genetics, metabolism)
- Signal Transduction
(drug effects)
|